Delaware
|
0-21019
|
33-0530289
|
(State or other jurisdiction of incorporation)
|
(Commission
File Number)
|
(I.R.S. Employer
Identification Number)
|
Exhibit No.
|
Description
|
|
99.1
|
Press release of Pure Bioscience, Inc., dated October 30, 2012.
|
PURE BIOSCIENCE, INC.
|
||||
Dated: October 30, 2012
|
By:
|
/s/ Michael L. Krall
|
||
Michael L. Krall
President, Chief Executive Officer
|
NEWS | ![]() |
July 31,
|
July 31,
|
|||||||
2012
|
2011
|
|||||||
Assets
|
||||||||
Current assets
|
||||||||
Cash and cash equivalents
|
$ | 877,000 | $ | 1,794,000 | ||||
Accounts receivable, net
|
373,000 | 50,000 | ||||||
Inventories, net
|
654,000 | 861,000 | ||||||
Prepaid expenses
|
347,000 | 100,000 | ||||||
Total current assets
|
2,251,000 | 2,805,000 | ||||||
Property, plant and equipment, net
|
257,000 | 426,000 | ||||||
Patents, net
|
1,950,000 | 1,917,000 | ||||||
Total assets
|
$ | 4,458,000 | $ | 5,148,000 | ||||
Liabilities and stockholders' equity
|
||||||||
Current liabilities
|
||||||||
Accounts payable
|
$ | 1,946,000 | $ | 677,000 | ||||
Loan payable, net
|
962,000 | - | ||||||
Accrued liabilities
|
344,000 | 258,000 | ||||||
Derivative liability
|
319,000 | - | ||||||
Deferred revenue
|
66,000 | - | ||||||
Total current liabilities
|
3,637,000 | 935,000 | ||||||
Deferred rent
|
3,000 | 6,000 | ||||||
Total liabilities
|
3,640,000 | 941,000 | ||||||
|
||||||||
Commitments and contingencies (Note 7)
|
||||||||
Stockholders' equity
|
||||||||
Preferred stock, $0.01 par value:
|
||||||||
5,000,000 shares authorized, no shares issued
|
- | - | ||||||
Common stock, $0.01 par value:
|
||||||||
100,000,000 shares authorized
|
||||||||
6,644,555 issued and outstanding at July 31, 2012, and
|
||||||||
5,004,275 issued and outstanding at July 31, 2011.
|
67,000 | 50,000 | ||||||
Additional paid-in capital
|
63,251,000 | 57,767,000 | ||||||
Accumulated deficit
|
(62,500,000 | ) | (53,610,000 | ) | ||||
Total stockholders' equity
|
818,000 | 4,207,000 | ||||||
Total liabilities and stockholders' equity
|
$ | 4,458,000 | $ | 5,148,000 |
|
||||||||
Year ended
|
||||||||
July 31,
|
||||||||
|
2012
|
2011
|
||||||
Revenue
|
|
|||||||
Net product sales
|
$ | 812,000 | $ | 454,000 | ||||
License fees
|
- | 10,000 | ||||||
Total revenue
|
812,000 | 464,000 | ||||||
Operating costs and expenses
|
||||||||
Cost of goods sold
|
264,000 | 131,000 | ||||||
Selling, general and administrative
|
7,439,000 | 6,520,000 | ||||||
Research and development
|
1,863,000 | 2,180,000 | ||||||
Total operating costs and expenses
|
9,566,000 | 8,831,000 | ||||||
Loss from operations
|
(8,754,000 | ) | (8,367,000 | ) | ||||
Other income (expense)
|
||||||||
Change in derivative liability
|
11,000 | - | ||||||
Interest expense
|
(145,000 | ) | - | |||||
Interest income
|
1,000 | 8,000 | ||||||
Other (expense) income, net
|
(3,000 | ) | 10,000 | |||||
Total other (expense) income
|
(136,000 | ) | 18,000 | |||||
Net loss
|
$ | (8,890,000 | ) | $ | (8,349,000 | ) | ||
Basic and diluted net loss per share
|
$ | (1.58 | ) | $ | (1.79 | ) | ||
Shares used in computing basic
|
||||||||
and diluted net loss per share
|
5,623,453 | 4,665,371 |
AI/$EO2&M].KMT MC4UGCRFU!Z)*3,:)9='?CFW202".\'QP1SI&O5ZX=7XN,SX\=\C!D1'DR8DI M`/?C(QY*`4,]U=C-W&*Y7[:V4Y723CK:?DS5?A]:2GO4EYHI^V^D/&,4&?#CJ 5N*(2D?23W#K5^W*%HN,W'F MS;79UB2?N3H@H<+A\L))-25LOUID/,08!=!5E*$"*XVE(`)ZE(`&U3615%\H M5]R+Q+9KC.S:-!X16O2>@K*XEW4UCE7F:4KFR43&PDD#U6T#.0A.3C.Y))., MX%A1]4:?DO)9C7RUO.J]EMN6VI1]P!R:R[G<8EL8[:<\AI!V2#NI1\$@;D^0 MK5)[5_U4OLF4KLUH)W<='W=P>2.[Z?MJK*?-N4O$M0@X)16M(U/7^K4SIWQ; M`?8;4X>3M'GDM(2/-1(`\36PZ'5I'3$$_P"<5E>N+P';R/AC6_\`PI];9(^W MJ?+;-.Z?M^GX9CVUCDYCEQQ>[CI\5*[_`-0[JEL>0J*UYDWR\B$^5^FOPAL_ MZ:U^U61`U%9+A*3&@7BVRI"@2EIB4A:SC 0H!O3:,+EYL^TI2L$Q2 ME*`4-*4!R[Z3LN.QKYA+S[2%&U-X2I8!_A'NZKZX6;\,M(8W'Q/#_L45.2[9 M!F.!R7"BON` !6IQU79.S?U%;Z+DR$:<8#.H[9`;#CV&'F4K4G[JO D2)'A,!F&PU'93T;:0$)'T#:@*[@N*:TFIVV7ZVR[.AM6(MRCH!*` M=TJ4%8_J]]?NVW%I&IM.3KE';@Q9%K4W&1R\C;3I*=DYZ>J/>`L#QK=UV.U+ ME_"UVR"J5GF[8QT%>?'FQG-94N*Q,84Q+9;?95[3;J`I)]X-`:_=)5HE:FM# M`8$ZZ-E2VU,N?Z,C&ZUX/L]PSU)QWUI4U:?DEJP@I/\`EI8W.V>S;VZU:4"W MP[ CS)7 MPQCMM66=QHNI!:;CI2I>2!R`]J<$].G?6OQ+2[<)^HIMK<2W>(-T6IA>< \]]8J[-;%S?AB[="5+SS M=N6$%S/CS8S0&A714=%ITJJVLFU1U3"MA,K*NS!5GG4"H'!]K&>^MGM,N0JY M,(D:FM BT,I21MCJ!YT!ZMPX[;Y>0R@/D8+A&5$>&>M>]*4`I2E`*4I0 M"E*4`I2E`*4I0"E*4`I2E`*4I0"E*4`I2E`*4I0"E*4`I2E`*4I0"E*4`I2E '`*4I0'__V3\_ ` end